BioXcel Therapeutics (BTAI) Current Taxes (2020 - 2026)
BioXcel Therapeutics (BTAI) recorded quarterly Current Taxes of $46000.0 in Q1 2026, up 43.75% quarter-over-quarter from $32000.0 in Q4 2025, and down 29.23% on a YoY basis from $65000.0 in Q1 2025.
BioXcel Therapeutics (BTAI) Current Taxes (2020 - 2026) Analysis & Trends
BioXcel Therapeutics' Current Taxes history runs 7 years deep, the most recent figure standing at $46000.0 for Q1 2026.
- In Q1 2026, Current Taxes fell 29.23% year-over-year to $46000.0; the TTM figure through Mar 2026 stood at $46000.0 (down 29.23% YoY), while the FY2025 annual figure was $32000.0, down 64.84% from the prior year.
- Current Taxes was $46000.0 for Q1 2026 at BioXcel Therapeutics, up from $32000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $529000.0 in Q3 2022 to a low of $32000.0 in Q4 2025.
- Historically, Current Taxes has averaged $147705.9 across 5 years, with a median of $103000.0 in 2025.
- The sharpest annual moves came in 2022 and 2023: Current Taxes surged 165.83% in 2022, then sank 74.86% in 2023.
- A 5-year view of Current Taxes shows it stood at $82000.0 in 2022, then jumped by 41.46% to $116000.0 in 2023, then fell by 21.55% to $91000.0 in 2024, then tumbled by 64.84% to $32000.0 in 2025, then surged by 43.75% to $46000.0 in 2026.
- The last three Current Taxes figures came in at $46000.0 (Q1 2026), $32000.0 (Q4 2025), and $103000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 211.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 4.61 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.15 Mn |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 108,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 212,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 529,000.00 |
| Jun 30, 2022 | 258,000.00 |
| Mar 31, 2022 | 366,000.00 |
| Dec 31, 2021 | 302,000.00 |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 254,000.00 |